Question 1

How many shares of CERE does MARSHALL WACE, LLP own?

Accepted Answer

MARSHALL WACE, LLP previously held 0 shares of CERE (CEREVEL THERAPEUTICS HLDNG I) before exiting the position in 2024-Q3.

Question 2

What is MARSHALL WACE, LLP's CERE position worth?

Accepted Answer

MARSHALL WACE, LLP's CERE position was last reported at $0 in 2024-Q3 before the exit.

Question 3

Is MARSHALL WACE, LLP buying or selling CERE?

Accepted Answer

In 2024-Q3, MARSHALL WACE, LLP exited their CERE position entirely (-100.0% change in shares).

Question 4

When did MARSHALL WACE, LLP first buy CERE?

Accepted Answer

Based on available 13F filings, MARSHALL WACE, LLP first reported a position in CERE in 2020-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q2	Increased	1.9M	+52.9%	$76.4M	0.1%	—	50
2024-Q1	Increased	1.2M	+290.6%	$51.7M	0.1%	—	47
2023-Q4	New	312,962	-	$13.3M	0.0%	—	39
2021-Q2	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q1	Decreased	23,597	-65.2%	$324,000	0.0%	—	0
2020-Q4	New	67,772	-	$1.1M	0.0%	—	35

CERE7 quarters

CERE
7 quarters